OrAlert. COM

by

Transmetron

OrAlert Saliva Drug Test

Rapid, One - Step Oral Drug Test!
Easy To Use !

The 6 Panel OrAlert Test will detect:

• ORAL-691 - Marijuana, Cocaine, Amphetamines, Methamphetamines, Opiates, & PCP (DSF-765)

--- OR ---

• ORAL-694 - Marijuana, Cocaine, Amphetamines, Methamphetamines, Opiates & Benzodiazepines (DSF-765-031)

This device provides an easy and convenient, non-evasive method of for detection of multiple drugs in oral fluids. Its cutting edge technology offers a unique design eliminating urine collection altogether! No more controlled controlled collection sites! No more collection-site fees! The oral fluid drug test eliminates the need for special equipment, same sex collectors, and complicated training. The test can be performed on-site anytime, anywhere and offers immediate results.

How does it work? The test is a lateral flow chromatographic immunoassay for the qualitative detection of multiple drugs and their metabolites in oral fluids based on the principle of competitive binding. Simply drop the collected oral fluids specimen into the device sample well and read in 10 minutes. It’s that easy.

New ORALERT 6 Panel Oral Fluids Test has many advantages:

• New Technology for detection of parent THC
• New Design with less components
• Shelf-life up to 18 months
• Immediate Results
• No more urine collections
• Observed collections without privacy issues
• Non-evasive
• Eliminates need for same-gender sample collections
• No more collection costs
• Incredibly clear test results!
• Testing Integrity (difficult to adulterate)
• Results available immediately
• Complete testing kit includes all components for testing including an easy-to—follow procedure card that may eliminate potential procedural errors
• Best overall value regarding quality and price

OrAlert  - Oral Fluid Screen - Oral Drug Test
	Description ORAL-691 - OrAlert 6 - Oral Saliva Drug Test - Oral Fluid Screen This Oral Fluid Screen tests for: • Amphetamine (AMP) 50 ng/mL • Methamphetamine (mAMP) 50 ng/mL • Cocaine (COC) 20 ng/mL • Opiates (OPI) 40 ng/mL • Marijuana (THC) parent THC at 100 ng/mL and THC-COOH at 12 ng/mL • Phencyclidine (PCP) 10 ng/mL   NEW ORAL-694 - BZO replaces PCP!   HOW TO USE
RETAIL $39.95   Our Price Only $13.25 each.       LOW Price Guarantee!            CALL for BULK Pricing > > > > 801-738-3536 Select Quantity: Choose Configuration: Item ORAL-691 Item ORAL-694 (w/BZO) We are the source for discount pricing on OrAlert kits!

NEW -- Complete interactive instructions on How To Use the OrAlert!

? ? ?   Questions  ? ? ?

Give Us A Call

801-738-3536

Drug Testing FAQs

Drug Test FAQ

OrALert 6 oral drug screen delivers results in minutes. Save thousands of dollars in collection fees and lost labor time with Oralert 6 oral drug screen. Unlike urine-based tests OrALert 6 - oral fluid screen is ready to use anytime, in any location and anyone can be trained to use the test in minutes. No Waiting For Lab Results. Results In (10) Minutes - Built In Confirmation Chamber. Bathrooms Not Required.. OrALert 6 oral fluid screen provides a faster, easier saliva drug test with dramatic cost savings over your current method. Our oral drug screen  provides an easy and convenient, non-evasive method of for detection of multiple drugs in oral fluids. Oralert's cutting edge technology offers a unique design eliminating urine collection altogether! No more controlled collection! Stop paying collection-site fees! 

• OrALert picks up THC up to 24 hours instead of 10-12 hours like it's competitors

• OrALert 6 Observe collections without  donor privacy issues

• OrALert 6 is non-invasive

• OrALert eliminates collection site costs.

• OrALert is difficult to adulterate.

• OrALert  test results take only 10 minutes

• OrALert 6 has a 18 month shelf life

OrAlert 6 Oral Drug Screen - (DSF-765-031)

(AMP, mAMP, COC, OPI, THC, BZO) Box of 25

Shelf Life: 8-12 Months

• Tests for Parent Drug on (THC).
• Can Detect (THC) for up to 24 hours.
• Shelf Life of 12 - 24 Months.
• Low Cost.
• Test Comes in Two Parts (Collecting Swab and Test Device).
• No Need For Bathrooms.

The OraLert 6 Oral Drug Screen is an immunoassay based on the principle of competitive binding. A rapid, screening test for the simultaneous, qualitative detection of drugs and their metabolites in human oral fluid. The OraLert 6 Oral Drug Screen is a lateral flow chromatographic immunoassay for the qualitative detection of drugs and their metabolites in oral fluids. The OraLert Oral Drug Screen for drugs and their metabolites is a rapid, oral fluid-screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in human oral fluid.
 
The OraLert 6 Oral Drug Screen is an immunoassay based on the principle of competitive binding. Drugs that may be present in the oral fluid specimen compete against their respective drug conjugates for binding sites on their specific antibody.  During testing, a portion of the oral fluid specimen migrates upward by capillary action. A drug, if present in the oral fluid test below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will show up in the test line region of the specific drug strip.

The presence of drug above the cut-off concentration in the oral fluid specimen will saturate all the binding sites of the antibody. Therefore, the colored line will not form in the test line region.  A drug-positive oral fluid test will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative oral fluid test will generate a line in the test line region because of the absence of drug competition. To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred..
 
Discover significant cost savings from the OraLert 6 Oral Drug Screen, the oral fluid drug test that delivers results in minutes. OraLert 6 Oral Drug Screen provides a faster, easier screen with dramatic cost savings over your current method. Save thousands of dollars in collection fees and lost labor time with OraLert 6. Unlike urine-based tests OraLert-6 is ready to use anytime, in any location and anyone can be trained to use the test in minutes. No Waiting For Lab Results. Results In (10) Minutes - Built In Confirmation Chamber. Bathrooms Not Required.
 
The OraLert-6 Oral Drug Test contains membrane strips coated with drug-protein conjugates on the test line, polyclonal antibody against gold-protein conjugate at the control line, and a dye pad which contains colloidal gold particles coated with antibody specific to the drugs being tested.  The OraLert-6 specimen should be collected using the collecting swab provided with the kit, following the detailed instructions under Directions for Use. No other collection devices should be used with this assay. Oral fluid collected at any time of the day may be used. Allow the OraLert-6 Oral Fluid test to come to room temperature (59-86F) prior to testing. Instruct the donor not to place anything in the mouth including food, drink, gum, or tobacco products for at least 10 minutes prior to collection.
 
Detecting drug use with a saliva drug test is a clean and easy drug screening technique. Saliva specimens are collected while the donor is under observation, which makes it harder for the donor to tamper with the results. OraLert-6 Oral Fluid Drug Screen collection process is much less invasive and embarrassing than urine drug testing. We offer quality saliva oral fluid drug test kits. The OraLert-6 Oral Fluid Drug Screen oral drug test is a dynamic saliva drug test kit detecting up to 5 drugs. Our saliva drug test kit detects traces of drugs (or drug metabolites) in oral fluids from the donor. Since drugs and drug metabolites (residues) do not remain in oral fluids as long as they do in urine, this method shows more promise in determining current use and impairment.
 
ASSAY PRINCIPLE
The OrAlert 6 Oral Fluid Drug Test oral screen is a saliva drug test for drugs that may be present in the oral fluid specimen. These drugs compete against their respective drug conjugates for binding sites on their specific antibody. During testing, a portion of the oral fluid specimen migrates upward by capillary action. A drug, if present in the oral fluid specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will show up in the test line region of the specific drug strip. The presence of drug above the cut-off concentration in the oral fluid specimen will saturate all the binding sites of the antibody. Therefore, the colored line will not form in the test line region.
 
A drug-positive oral fluid test specimen will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative oral fluid specimen will generate a line in the test line region because of the absence of drug competition. To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.
 
REAGENTS
The OrAlert 6 Oral Fluid Drug Test Oral Screen contains membrane strips coated with drug-protein conjugates on the test line, polyclonal antibody against gold-protein conjugate at the control line, and a dye pad which contains colloidal gold particles coated with antibody specific to the drugs being tested.
 
SPECIMEN COLLECTION AND PREPARATION
The OrAlert 6 Oral Fluid Drug Test oral screen specimen should be collected using the collecting swab provided with the kit, following the detailed instructions

under Directions for Use. No other collection devices should be used with this assay. Oral fluid collected at any time of the day may be used.
 
DIRECTIONS FOR USE
Allow the OrAlert Oral fluid screen to come to room temperature (59-86F) prior to testing. Instruct the donor not to place anything in the mouth including food, drink, gum, or tobacco products for at least 10 minutes prior to collection.

1. Bring the OrAlert 6 oral fluid screen - saliva Drug test pouch to room temperature before opening it. Remove the test and Cap from the sealed pouch and use the test as soon as possible.
2. Remove the OrAlert-6 oral screen- saliva Drug test Device Sample Collector Cap from the collection Swab. Instruct the donor to insert the Swab end of the collector into the mouth and actively swab the inside of the mouth and the top of the tongue. As soon as the Swab softens slightly, the donor should gently press the Swab between the tongue and teeth to ensure complete saturation.
3. The Swab is saturated when no hard spots can be felt. Collect for a total of at least three (3) minutes before removing the Swab. Remove the collector from the mouth.

4. Align the Red Arrow on the OrAlert 6 oral screen fluid drug screen with one of the White Marks on the Cap. Insert the collector vertically into the Cap and press down firmly. Twist the Cap clockwise 180 degrees until the Red Arrow lines up with the other White Mark.
5. Place the test device horizontally on a clean and level surface with facing up.
6. Read results at 10 minutes. Do not read results after 1 hour.
7. If positive results are observed, secure Cap with security seal and send the OrAlert 6 Oral Screen fluid drug screen to a laboratory for confirmation. The laboratory can access the reservoir through the Sample Port.
 
How to Read Results
 
NEGATIVE: Two lines appear.
One colored line should be in the control region (C), and another apparent colored line should be adjacent in the test region (Drug/T). This negative result indicates that the drug concentration is below the detectable level.
NOTE: The shade of color in the test region (Drug/T) will vary, but it should be considered negative whenever there is even a faint colored line.
 
POSITIVE: One colored line appears in the control region (C). No line appears in the test region (Drug/T). This positive result indicates that the drug concentration is above the detectable level.
 
INVALID: Control line fails to appear.
Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test panel. If the problem persists, discontinue using the lot immediately and contact the manufacturer. A procedural control is included in the test. A colored line appearing in the control region (C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique.

LIMITATIONS
1. The OrAlert 6 oral screen fluid drug screen provides only a qualitative, preliminary analytical result. A secondary analytical method must be used to obtain a confirmed result. Gas chromatography/mass spectrometry (GC/MS) or gas chromatography/tandem mass spectrometry (GC/MS/MS) are preferred confirmatory methods.
2. A positive test result does not indicate the concentration of drugs in the specimen or the route of administration.
3. A negative result may not necessarily indicate a drug-free specimen. Drugs may be present in the specimen below the cutoff level of the assay.
 
Cross-Reactivity
A study was conducted to determine the cross-reactivity of the test with compounds spiked into drug-free PBS stock. The compounds demonstrated no false positive results on the OrAlert 6 fluid drug screen when tested with concentrations up to 100 mL.

The OrALert™ Oral Fluid Drug Screen Device for AMP/mAMP/COC/OPI/THC/PCP and their metabolites is a rapid, oral fluid screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in human oral fluid.

The OrALert™ Oral Fluid Drug Screen Device is a lateral flow chromatographic immunoassay for the qualitative detection of amphetamine, methamphetamine, cocaine, opiates, marijuana, phencyclidine and their metabolites in oral fluids at the following cut-off concentrations:

Amphetamine (AMP)

Amphetamine is a sympathomimetic amine with therapeutic indications. The drug is often self administered by nasal inhalation or oral ingestion. Depending on the route of administration, amphetamine can be detected in oral fluid as early as 5-10 minutes following use1. Amphetamine can be detected in oral fluids for up to 72 hours after use.

The Amphetamine assay contained within the OrALert™ Oral Fluid Drug Screen Device yields a positive result when the amphetamine concentration in oral fluid exceeds 50 ng/mL.

Methamphetamine (MAMP)

Methamphetamine is a potent stimulant chemically related to amphetamine but with greater CNS stimulation properties. The drug is often self-administered by nasal inhalation, smoking or oral ingestion. Depending on the route of administration, methamphetamine can be detected in oral fluid as early as 5- 10 minutes following use.

The Methamphetamine assay contained within the OrALert™ Oral Fluid Drug Screen Device yields a positive result when the methamphetamine concentration in oral fluid exceeds 50 ng/mL.

Cocaine (COC)

Cocaine is a potent central nervous system (CNS) stimulant and a local anesthetic derived from the coca plant (erythroxylum coca). The drug is often self-administered by nasal inhalation, intravenous injection and free-base smoking. Depending on the route of administration, cocaine and metabolites benzoylecgonine and ecgonine methyl ester can be detected in oral fluid as early as 5-10 minutes following use.

The Cocaine assay contained within the OrALert™ Oral Fluid Drug Screen Device yields a positive result when the cocaine metabolite concentration in oral fluid exceeds 20 ng/mL.

Opiates (OPI)

The drug class opiates refers to any drug that is derived from the opium poppy, including naturally occurring compounds such as morphine and codeine and semi-synthetic drugs such as heroin. Opiates act to control pain by depressing the central nervous system. The drugs demonstrate addictive properties when used for sustained periods of time; symptoms of withdrawal may include sweating, shaking, nausea and irritability. Opiates can be taken orally or by injection routes including intravenous, intramuscular and subcutaneous; illegal users may also take the intravenously or by nasal inhalation. Using an immunoassay cutoff level of 40 ng/mL, codeine can be detected in the oral fluid within 1 hour following a single oral dose and can remain detectable for 7-21 hours after the dose. Heroin metabolite 6-monoacetylmorphine (6-MAM) is found more prevalently in excreted unmetabolized, and is also the major metabolic product of codeine and heroin. Morphine is detectable in the urine for several days after an opiate dose.

The Opiates assay contained within the OrALert™ Oral Fluid Drug Screen Device yields a positive result when the morphine concentration in oral fluid exceeds 40 ng/mL.

Marijuana (THC)

Tetrahydrocannabinol, the active ingredient in the marijuana plant (cannabis sativa), is detectable in saliva shortly after use. The detection of the drug is thought to be primarily due to the direct exposure of the drug to the mouth (oral and smoking administrations) and the subsequent sequestering of the drug in the buccal cavity. Historical studies have shown a window of detection for THC in saliva of up to 14 hours after drug use.

The THC assay contained within the OrALert™ Oral Fluid Drug Screen Device yields a positive result when the ∆9-THC concentration in oral fluid exceeds 100 ng/mL.

Phencyclidine (PCP)

Phencyclidine, the hallucinogen commonly referred to as Angel Dust, can be detected in saliva as a result of the exchange of the drug between the circulatory system and the oral cavity. In a paired serum and saliva sample collection of 100 patients in an Emergency Department, PCP was detected in the saliva of 79 patients at levels as low as 2 ng/mL and as high as 600 ng/mL4.

The Phencyclidine assay contained within the OrALert™ Oral Fluid Drug Screen Device yields a positive result when the PCP concentration in oral fluid exceeds 10 ng/mL.

This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) and gas chromatography/tandem mass spectrometry (GC/MS/MS) are the preferred confirmatory methods. Professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. For more information, click here.